UNSPSC 51293011: Amineptine sodium

This classification denotes an antidepressant agent with the molecular formula C22H26NO2.NA, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6BYR55117P. European Medicines Agency schedules amineptine sodium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00448MIG. Most nations, for tariff and trade purposes, schedule amineptine sodium under HS 29224995 and SITC 51465. As of Q4 2014, AMINEPTINE SODIUM remains US FDA's Preferred Term for this commodity.

SMILES: C1CCC2C(C1)CCC3CCCCC3C2NCCCCCCC(=O)[O-].[NA+].

UNSPSC 51293011 Amineptine sodium is a Commodity code that designates a specific pharmaceutical product, yet the recent state and local opportunity tagged under it reflects a significant mismatch between the code's nominal scope and actual procurement activity. Seminole County, Florida's June 2026 IFB for naloxone and drug deactivation systems bears no relation to amineptine sodium, an antidepressant medication. This disconnect suggests either a cataloging error in the source opportunity or inconsistent code assignment by the issuing body. State and local governments tag pharmaceuticals and medical supplies with varying precision, and narrow commodity codes like this one are particularly vulnerable to miscoding when procurement offices map complex multi-item purchases to the taxonomy. The recent record provides no evidence of authentic demand for amineptine sodium at the state or local level; the single posted opportunity is plainly unrelated to the code's definition.

No recent state and local solicitations for amineptine sodium itself appear in the source. The code shows little relevant recent activity, and the one tagged opportunity—Seminole County's naloxone procurement—is a pharmaceutical supply purchase that falls outside the scope of this specific commodity code. Business development professionals should verify whether amineptine sodium is actually procured by state and local governments in the United States, and whether genuine opportunities under this code exist in less-indexed procurement channels or through cooperative purchasing agreements that have not surfaced in recent public postings.